BRUCE D GIVEN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BRUCE D GIVEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BRUCE D GIVEN. BRUCE D GIVEN is President & CEO in ENCYSIVE PHARMACEUTICALS INC ($ENCY) and Chief Operating Officer in ARROWHEAD PHARMACEUTICALS, INC. ($ARWR).
Latest Insider Trading Transactions of BRUCE D GIVEN
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | M | 5.20 | 213 | 1,108 | 329,347 | |
| Apr 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | M | 5.19 | 830 | 4,308 | 329,560 | |
| Apr 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | M | 4.75 | 1,200 | 5,700 | 330,390 | |
| Apr 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | M | 14.54 | 1,454 | 21,141 | 331,590 | |
| Apr 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | M | 7.75 | 500 | 3,875 | 333,044 | |
| Apr 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | M | 5.19 | 200 | 1,038 | 333,544 | |
| Apr 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 40.00 | 700 | 28,000 | 850,730 | 851.4 K to 850.7 K (-0.08 %) |
| Apr 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 40.00 | 204 | 8,160 | 851,430 | 851.6 K to 851.4 K (-0.02 %) |
| Apr 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 40.00 | 213 | 8,520 | 851,634 | 851.8 K to 851.6 K (-0.03 %) |
| Apr 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 40.00 | 830 | 33,200 | 851,847 | 852.7 K to 851.8 K (-0.10 %) |
| Apr 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 40.00 | 1,200 | 48,000 | 852,677 | 853.9 K to 852.7 K (-0.14 %) |
| Apr 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 40.00 | 1,454 | 58,160 | 853,877 | 855.3 K to 853.9 K (-0.17 %) |
| Apr 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 40.00 | 500 | 20,000 | 855,331 | 855.8 K to 855.3 K (-0.06 %) |
| Apr 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Buy | M | 5.20 | 213 | 1,108 | 855,831 | 855.6 K to 855.8 K (+0.02 %) |
| Apr 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Buy | M | 5.19 | 830 | 4,308 | 855,618 | 854.8 K to 855.6 K (+0.10 %) |
| Apr 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Buy | M | 4.75 | 1,200 | 5,700 | 854,788 | 853.6 K to 854.8 K (+0.14 %) |
| Apr 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Buy | M | 14.54 | 1,454 | 21,141 | 853,588 | 852.1 K to 853.6 K (+0.17 %) |
| Apr 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Buy | M | 7.75 | 500 | 3,875 | 852,134 | 851.6 K to 852.1 K (+0.06 %) |
| Apr 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 40.00 | 100 | 4,000 | 851,634 | 851.7 K to 851.6 K (-0.01 %) |
| Apr 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 40.00 | 200 | 8,000 | 851,734 | 851.9 K to 851.7 K (-0.02 %) |
| Apr 29 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Buy | M | 5.19 | 200 | 1,038 | 851,934 | 851.7 K to 851.9 K (+0.02 %) |
| Apr 22 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | M | 14.54 | 5,300 | 77,062 | 333,744 | |
| Apr 22 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | M | 5.20 | 3,456 | 17,971 | 339,044 | |
| Apr 22 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | M | 5.19 | 3,700 | 19,203 | 342,500 | |
| Apr 22 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | M | 4.75 | 3,800 | 18,050 | 346,200 | |
| Apr 22 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 40.00 | 3,805 | 152,200 | 851,734 | 855.5 K to 851.7 K (-0.44 %) |
| Apr 22 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 40.00 | 3,454 | 138,160 | 855,539 | 859 K to 855.5 K (-0.40 %) |
| Apr 22 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 40.00 | 5,300 | 212,000 | 858,993 | 864.3 K to 859 K (-0.61 %) |
| Apr 22 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 40.00 | 3,456 | 138,240 | 864,293 | 867.7 K to 864.3 K (-0.40 %) |
| Apr 22 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 40.00 | 3,700 | 148,000 | 867,749 | 871.4 K to 867.7 K (-0.42 %) |
| Apr 22 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 40.00 | 3,800 | 152,000 | 871,449 | 875.2 K to 871.4 K (-0.43 %) |
| Apr 22 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Buy | M | 14.54 | 5,300 | 77,062 | 875,249 | 869.9 K to 875.2 K (+0.61 %) |
| Apr 22 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Buy | M | 5.20 | 3,456 | 17,971 | 869,949 | 866.5 K to 869.9 K (+0.40 %) |
| Apr 22 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Buy | M | 5.19 | 3,700 | 19,203 | 866,493 | 862.8 K to 866.5 K (+0.43 %) |
| Apr 22 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Buy | M | 4.75 | 3,800 | 18,050 | 862,793 | 859 K to 862.8 K (+0.44 %) |
| Jan 08 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 60.99 | 1,300 | 79,287 | 858,993 | 860.3 K to 859 K (-0.15 %) |
| Jan 08 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 60.37 | 22,466 | 1,356,272 | 860,293 | 882.8 K to 860.3 K (-2.54 %) |
| Jan 08 2020 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 59.57 | 11,847 | 705,726 | 882,759 | 894.6 K to 882.8 K (-1.32 %) |
| Mar 01 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | M | 2.01 | 42,500 | 85,425 | 350,000 | |
| Mar 01 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 19.99 | 42,500 | 849,575 | 644,606 | 687.1 K to 644.6 K (-6.19 %) |
| Mar 01 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Buy | M | 2.01 | 42,500 | 85,425 | 687,106 | 644.6 K to 687.1 K (+6.59 %) |
| Feb 27 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | M | 2.01 | 42,500 | 85,425 | 392,500 | |
| Feb 27 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 18.98 | 42,500 | 806,650 | 644,606 | 687.1 K to 644.6 K (-6.19 %) |
| Feb 27 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Buy | M | 2.01 | 42,500 | 85,425 | 687,106 | 644.6 K to 687.1 K (+6.59 %) |
| Feb 20 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | M | 2.01 | 42,500 | 85,425 | 435,000 | |
| Feb 20 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 17.98 | 42,500 | 764,150 | 644,606 | 687.1 K to 644.6 K (-6.19 %) |
| Feb 20 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Buy | M | 2.01 | 42,500 | 85,425 | 687,106 | 644.6 K to 687.1 K (+6.59 %) |
| Feb 20 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 17.67 | 26,250 | 463,838 | 644,606 | 670.9 K to 644.6 K (-3.91 %) |
| Feb 12 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | M | 2.01 | 42,500 | 85,425 | 477,500 | |
| Feb 12 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | M | 2.62 | 11,667 | 30,568 | 520,000 | |
| Feb 12 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | M | 2.62 | 11,667 | 30,568 | 531,667 | |
| Feb 12 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 17.06 | 42,500 | 725,050 | 670,856 | 713.4 K to 670.9 K (-5.96 %) |
| Feb 12 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Buy | M | 2.01 | 42,500 | 85,425 | 713,356 | 670.9 K to 713.4 K (+6.34 %) |
| Feb 12 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 16.48 | 57,000 | 939,360 | 670,856 | 727.9 K to 670.9 K (-7.83 %) |
| Feb 12 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 15.66 | 97,167 | 1,521,635 | 727,856 | 825 K to 727.9 K (-11.78 %) |
| Feb 12 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Buy | M | 2.62 | 11,667 | 30,568 | 825,023 | 813.4 K to 825 K (+1.43 %) |
| Feb 12 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 15.34 | 46,167 | 708,202 | 813,356 | 859.5 K to 813.4 K (-5.37 %) |
| Feb 12 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Buy | M | 2.62 | 11,667 | 30,568 | 859,523 | 847.9 K to 859.5 K (+1.38 %) |
| Feb 07 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 14.48 | 22,500 | 325,800 | 847,856 | 870.4 K to 847.9 K (-2.59 %) |
| Feb 01 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 13.85 | 28,500 | 394,725 | 870,356 | 898.9 K to 870.4 K (-3.17 %) |
| Jan 24 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 13.15 | 17,500 | 230,125 | 898,856 | 916.4 K to 898.9 K (-1.91 %) |
| Jan 24 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 13.59 | 152,000 | 2,065,680 | 916,356 | 1.1 M to 916.4 K (-14.23 %) |
| Jan 16 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | M | 6.20 | 1,000 | 6,200 | 543,334 | |
| Jan 16 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | M | 2.62 | 11,666 | 30,565 | 544,334 | |
| Jan 16 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 14.40 | 42,666 | 614,390 | 1,068,356 | 1.1 M to 1.1 M (-3.84 %) |
| Jan 16 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Buy | M | 6.20 | 1,000 | 6,200 | 1,111,022 | 1.1 M to 1.1 M (+0.09 %) |
| Jan 16 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Buy | M | 2.62 | 11,666 | 30,565 | 1,110,022 | 1.1 M to 1.1 M (+1.06 %) |
| Jan 03 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 11.98 | 20,000 | 239,600 | 1,098,356 | 1.1 M to 1.1 M (-1.79 %) |
| Jan 03 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Grant | A | 0.00 | 210,000 | 0 | 1,118,356 | 908.4 K to 1.1 M (+23.12 %) |
| Mar 05 2018 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 6.73 | 20,000 | 134,600 | 908,356 | 928.4 K to 908.4 K (-2.15 %) |
| Jan 03 2018 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 3.69 | 20,000 | 73,800 | 928,356 | 948.4 K to 928.4 K (-2.11 %) |
| Jan 03 2018 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Grant | A | 0.00 | 175,000 | 0 | 948,356 | 773.4 K to 948.4 K (+22.63 %) |
| Jan 04 2017 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Grant | A | 0.00 | 380,000 | 0 | 773,356 | 393.4 K to 773.4 K (+96.60 %) |
| Mar 08 2016 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Payment of Exercise | F | 4.33 | 13,675 | 59,213 | 393,356 | 407 K to 393.4 K (-3.36 %) |
| Feb 09 2016 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Payment of Exercise | F | 3.46 | 17,969 | 62,173 | 407,031 | 425 K to 407 K (-4.23 %) |
| Jan 04 2016 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | A | 6.15 | 60,000 | 369,000 | 556,000 | |
| Jan 04 2016 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Grant | A | 0.00 | 150,000 | 0 | 425,000 | 275 K to 425 K (+54.55 %) |
| Mar 06 2015 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | A | 7.75 | 60,000 | 465,000 | 496,000 | |
| Mar 06 2015 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Grant | A | 0.00 | 150,000 | 0 | 275,000 | 125 K to 275 K (+120.00 %) |
| Aug 04 2004 | ENCY | ENCYSIVE PHARMACEU ... | GIVEN BRUCE D | President & CEO | Buy | P | 5.85 | 5,000 | 29,269 | 219,982 | 215 K to 220 K (+2.33 %) |
| Mar 05 2004 | ENCY | ENCYSIVE PHARMACEU ... | GIVEN BRUCE D | President & CEO | Option Exercise | A | 9.85 | 118,750 | 1,169,688 | 118,750 | |
| Mar 05 2004 | ENCY | ENCYSIVE PHARMACEU ... | GIVEN BRUCE D | President & CEO | Grant | A | 0.00 | 8,799 | 0 | 214,982 | 206.2 K to 215 K (+4.27 %) |
Page: 1